In this congressionally mandated study, an expert committee of the Institute of Medicine takes a close look at where treatment for people with alcohol problems seems to be headed, and provides its best advice on how to get there. Careful consideration is given to how the creative growth of treatment can best be encouraged while keeping costs within reasonable limits. Particular attention is devoted to the importance of developing therapeutic approaches that are sensitive to the special needs of the many diverse groups represented among those who have developed problems related to their use of "man's oldest friend and oldest enemy." This book is the most comprehensive examination of alcohol treatment to date.

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

This clinical guideline, commissioned by the National Institute for Health and Clinical Excellence (NICE) sets out clear recommendations, based on the best available evidence, for health care professionals on how to work with people with alcohol use disorders, in order to improve their treatment and care. About a quarter of the UK population drink alcohol at a level that is harmful and over 4% are dependent. Alcohol use disorders are also increasing in children and young people. This new guideline reviews the evidence for the diagnosis and assessment of alcohol use disorders, organisation and delivery of care, assisted alcohol withdrawal, and psychological and pharmacological interventions, and includes a chapter on experience of care. It comes with a free CD-ROM that contains all the data used as evidence, including: included and excluded studies, profile tables that summarise both the quality of the evidence and the results of the evidence synthesis, all meta-analytical data, presented as forest plots and detailed information about how to use and interpret forest plots.

A revision of the landmark study by D.J. Lettieri "Alcoholism Treatment Assessment Research Instruments". Assists in locating, examining, and selecting instruments appropriate for use in all stages of the assessment process. Includes state-of-the-art reviews of and recommendations for assessment procedures. Written with the clinician and the less experienced researcher in mind. Includes screening, diagnosis, assessment of drinking behavior, treatment planning, treatment and process assessment, and outcome evaluation. Also Fact Sheets and Sample Instruments.

Alcohol abuse and alcohol dependence are widespread, and the individual and societal problems associated with these disorders have made the study and treatment of alcohol use disorders a clinical research priority. Research over the past several decades has led to the development of excellent empirically supported treatment methods. This book aims to increase clinicians' access to empirically supported interventions for alcohol use disorders, with the hope that these methods will become the standard in clinical practice.

This Handbook provides a contemporary and research-informed review of the topics essential to clinical psychological assessment and diagnosis. It outlines assessment issues that cross all methods, settings, and disorders, including (but not limited to) psychometric issues, diversity factors, ethical dilemmas, validity of patient presentation, psychological assessment in treatment, and report writing. These themes run throughout the volume as leading researchers summarize the empirical findings and technological advances in their area. With each chapter written by major experts in their respective fields, the text gives interpretive and practical guidance for using psychological measures for assessment and diagnosis.

Adolescent alcohol use is prominent among today′s teens and has elicited rising concerns among parents, health practitioners, social policymakers, and the public at large. Yet there is an absence of a relatively concise book that summarizes and integrates existing knowledge on the various facets of adolescent alcohol use. This book attempts to fill this void by integrating research from the multiple fields of study (e.g., prevalence of use), describing measurement approaches (e.g., survey and clinical diagnostic), reviewing risk and protective factors, reporting on findings from prominent prevention and treatment studies, and suggesting future research directions. The coverage is intended to examine issues relevant to etiology, developmental courses, and prevention and treatment, as well as to identify future research directions.

This book serves as a tool for general psychiatrists, medical students, residents, and fellows looking for a clinically relevant and high-yield overview of addiction psychiatry in preparation for their board exams – or for everyday clinical practice. Written by expert educators in addiction psychiatry, the text is organized by substances misused and populations affected. This book serves as both a primary learning tool for those new to the field, as well as a reference for those working in addiction treatment. Each chapter begins with summaries of high yield clinical pearls, followed by general information including treatment, and then ends with accompanying board-style review questions. The scope includes understanding substances of misuse and substance use disorders (SUDs), how to evaluate, diagnose, and monitor SUDs, how to treat SUDs both pharmacologically and behaviorally, and critical information for specific populations of patients. Absolute Addiction Psychiatry for Clinical Practice and Review is an excellent resource for all medical students, residents, fellows, and professionals taking certification exams in addiction, including those in psychiatry, addiction medicine, emergency medicine, internal medicine, pain medicine, and others. The chapter "Laboratory Testing for Substance Use Disorders" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.